Navigation Links
New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes

phrol. 2001; 12:2735-8.

(6) Bakris G et al. Comparative long term effects of two AT1 receptor blockers on proteinuria in patients with type-2 diabetes and overt nephropathy and hypertension: results of the AMADEO trial.Presented at the Annual Meeting of the American Society of Hypertension. May 2007, Chicago, USA

(7) Burnier M, Brunner HR. Lancet 2000;355:637-45.

(8) Brunner HR. J Hum Hypertens 2002;16(suppl 2):S13-S16.

(9) Neutel JM, Smith HG. J Clin Hypertens 2003;5(1):58-63.

(10) Millar-Craig MW et al. Lancet 1978;1:795-97.

For further information: Dr. Reinhard Malin, Corporate Division Communications, Boehringer Ingelheim GmbH, 55216 Ingelheim/Germany, Phone: +49-6132 -77-90815, Fax: +49-6132-72-6601, E-mail: press@boehringer-ingelheim.com



'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/8/2008)... May 8 /- Alpharma Inc. (NY...any, today announced results from,clinical trials ...extended-release with sequestered naltrexone hydro...t features addressing abuse liability,alongside a ... and II,studies, presented at the 27th Annual Scie...
(Date:5/8/2008)...onn., May 8 /- VION PHARMAC...e start of an investigator-sponsored,Phase I/II cl...ine(R),(VNP40101M) in combination with cytarabine ...e myelogenous leukemia (AML) and high-risk,myelody...cted under the,direction of Ellen K. Ritchie, M.D....
(Date:5/8/2008)...an-Kettering Cancer Center Investigators to Assess...n Cancer Patients -, BRISBANE, Calif., May 8 /PRN...he expansion of Phase 2 clinical trial programs fo...is is the third major clinical trial,of BSI-201 th...ing on,on-going trials in breast and brain cancer....
(Date:5/8/2008)... 8 /- Go Healthy (Pink Shee...ical trials with Cholesterade (R),in three medical...of 200,patients in 6 centers around the country. D...at The Methodist Hospital in the Texas Medical Cen...was formerly the Team,Physician for the Houston As...
Breaking Medicine Technology:Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Go Healthy Initiates Additional Clinical Tests on Cholesterade 2Marriage for a New World 16877 1Marriage for a New World 16877 2Prolonged Fasting Boosts Risk of Rare Stroke 16874 1Prolonged Fasting Boosts Risk of Rare Stroke 16874 2Avalere Health Data Finds Four Tier System Growing Among Medicare Part D Plans 16869 1Avalere Health Data Finds Four Tier System Growing Among Medicare Part D Plans 16869 2Illinois House to Hold Appropriation Hearing on Improving Access to Dental Care for More Than 2 Million Children and Adults 16864 1Illinois House to Hold Appropriation Hearing on Improving Access to Dental Care for More Than 2 Million Children and Adults 16864 2Illinois House to Hold Appropriation Hearing on Improving Access to Dental Care for More Than 2 Million Children and Adults 16864 3
...SO VIEJO, Calif.--(BUSINESS WIRE)--Jun 8, 2007 - A...d the presentation of,Phase III data, including ef...d outcomes in patients with diabetic peripheral,ne...nal drug,Zenvia(TM) (dextromethorphan/quinidine (D...nist. The data were accepted as,late-breakers, an...
...ull; Data presented at Movement Disorder Society&r...ent of cognitive impairment in early,Parkinson&rsq...need , ,Geneva, Switzerland, June 8, 2007 – ...wron Pharmaceuticals S.p.a. (SWX:,NWRN) announced ...gent in Phase III development for the treatment of...
Other Medicine Technology:AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 2AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 3AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 4AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 5AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 6AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 7Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 2Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 3Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 4Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 5Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 6Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 7
(Date:5/11/2008)... and safely used at home , , SUNDAY, May...ing cleaning, don,t forget your nose. , Nasal i...spring allergies, nasal congestion, stuffy noses a... Pynnonen, co-director of the Michigan Sinus Cente...Michigan,s department of otolaryngology. , Nasa...
(Date:5/10/2008)...ldren,s Hospital of Pittsburgh of,UPMC is just one...ospital,campus., (Photo: http://www.newscom.com/...ildren,s Hospital opens in May 2009, it will set t... hospital building will,serve as the centerpiece o...ated on a 10-acre campus. Located in the Lawrencev...
(Date:5/9/2008)...protection against heart disease ...8 /PRNewswire/ -- Brown rice, a 100 percent whole,...l whole grains, according,to an announcement this ...DA) that will allow brown rice food labels to bear...nsumers to easily identify brown rice as a food,to...
(Date:5/9/2008)...ry: With the recent devastating,cyclone in Myanmar...ver a,million people homeless, the need for relief...ci and Steve Jones have launched the Myanmar,Chall...umanitarian needs,with hopes of filling the need ...ving 1,000 individuals and companies take the Myan...
Breaking Medicine News(10 mins):Health News:Nasal Irrigation Can Help Fight Spring Allergies 2Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 2Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 3Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 4Health News:FDA Approves Health Claim for Brown Rice 2Health News:FDA Approves Health Claim for Brown Rice 3Health News:FDA Approves Health Claim for Brown Rice 4Health News:FDA Approves Health Claim for Brown Rice 5Health News:New Web Site to Raise Awareness for the Myanmar Crisis Has Lofty Goals 2
...h world but the death rate from it is falling due ...ers from the University of Southern Denmark carrie...0,000 people between 1993 and 1999. While the prop... by around three percent annually during the six-y...
...it suicide than other people, scientists said on F...s of more than 20,000 same-sex twins who died betw...ide with the wider population. They found that the...ardless of their sex.// The findings came as a sur...
...ck, the most important thing they can do to increa...to their heart is to get help as soon as possible....tional Heart, Lung, and Blood Institute, many peop...y experience heart attack symptoms because they do...
...hown to boost vitamin D levels and now researchers...r sun exposure during childhood and early adolesce...sclerosis, according to the study. Australian inve...which is located at high latitude and has a high p...
Other Medicine News:Health News:Recognize Heart Attack Signs 2
Helmer Platelet Agitators feature sturdy, one-piece perforated drawers with non-slip texture coating and provide complete air circulation for your platelets. Helmer agitators are designed to be used
...mer platelet agitators offer a wide range of stora... drawer storage platform to agitate smoothly, elim... and squeak. Sturdy, one-piece perforated drawers ... circulation for your platelets., ,i.Series pl...
Platelet agitator.
Platelet agitator.
Medicine Products: